In addition, we extend our appreciation to KetengEdit (www.ketengedit.com) for their linguistic assistance in the preparation of this manuscript
Ruhoy said on the Bendy Bodies podcast that she was not a big fan of supplements for most people
Different doses and different GLP-1 medications may carry different skeletal profiles
For study participants treated with tirzepatide (5 mg, 10 mg and 15 mg, respectively), nausea (11.6 percent, 13.2 percent, 18.2 percent), diarrhea (11.6 percent, 14.0 percent, 11.6 percent), vomiting (3.3 percent, 2.5 percent, 5.8 percent) and constipation (5.8 percent, 5.0 percent, 6.6 percent) were more frequently experienced compared to placebo (6.1 percent [nausea], 7.8 percent [diarrhea], 1.7 percent [vomiting], 0.9 percent [constipation])